๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Implantable vascular access devices in the treatment of colorectal liver metastases

โœ Scribed by C. G. Clark


Publisher
John Wiley and Sons
Year
1986
Tongue
English
Weight
270 KB
Volume
73
Category
Article
ISSN
0007-1323

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Role of neoadjuvant chemotherapy in the
โœ K. Tanaka; R. Adam; H. Shimada; D. Azoulay; F. Lรฉvi; H. Bismuth ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 117 KB ๐Ÿ‘ 1 views

## Abstract ## Background The role of neoadjuvant chemotherapy for patients with multiple (five or more) bilobar hepatic metastases irrespective of initial resectability is still under scrutiny. The purpose of this study was to compare the outcome of hepatectomy alone with that of hepatectomy afte

Neoadjuvant chemotherapy and resection o
โœ G. Mentha; P. E. Majno; A. Andres; L. Rubbia-Brandt; P. Morel; A. D. Roth ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 183 KB ๐Ÿ‘ 1 views

## Abstract ## Background In many patients with advanced synchronous liver metastases from colorectal tumours, the metastases progress during treatment of the primary, precluding curative treatment. The authors have investigated a management strategy that involves high-impact chemotherapy first, r

Prognostic index for the development of
โœ Professor I. Taylor; M. A. Mullee; M. J. Campbell ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 280 KB ๐Ÿ‘ 2 views

## Abstract The incidence of synchronous and metachronous liver metastases in patients with colorectal cancer is extremely high. Approximately 25 per cent of patients will have overt liver metastases at the time of presentation, and in the remainder up to 40 per cent will eventually develop liver m